Malcolm J. Moore

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• 1545P CS2009, a novel PD-1/VEGF/CTLA-4 trispecific antibody, in patients with advanced solid tumors: An open-label, multicenter, phase I first-in-human study

  Annals of Oncology · 2025-09-01 · 1 citations

• Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial

  Nature Communications · 2025-07-01 · 25 citations

• It's All in the Timing: Preliminary Data on an Alternative Tissue Plasminogen Activator (TPA) and Dornase Alfa (DNase) Dosing Schedule

  American Journal of Respiratory and Critical Care Medicine · 2025-05-01

• The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer

  npj Precision Oncology · 2025-04-04 · 1 citations

• Beyond Khorana score 2: Molecular correlates of venous thromboembolism in pancreatic cancer.

  Journal of Clinical Oncology · 2025-01-27

• Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial

  UNC Libraries · 2024-07-27